MO

Altria Group

Consumer Defensive Tobacco NYSE

About the company

Altria, a multinational conglomerate, is a powerhouse in the tobacco industry. With its subsidiaries including Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, and Helix Innovations, Altria commands a significant market share and holds a prominent position in the United States. In addition to its tobacco ventures, Altria has diversified its portfolio by investing in other sectors. One notable investment is Altria's 10% interest in Anheuser-Busch InBev, the world's largest brewer. This strategic partnership allows Altria to tap into the lucrative global beer market and diversify its revenue streams. The collaboration strengthens Altria's position in the consumer goods industry and provides opportunities for future growth. However, it is in the tobacco sector where Altria truly shines. Through its tobacco subsidiaries, the company reigns supreme in the U.S. market, dominating both the cigarette and smokeless tobacco segments. Altria's Marlboro brand, iconic and renowned, is the crown jewel in its cigarette portfolio. With an impressive 43% annual share in 2022, Marlboro boasts unparalleled popularity and consumer loyalty. But Altria's ambitions don't stop at tobacco. The company has set its sights on the emerging cannabis industry. Altria holds a significant 42% stake in Cronos, a leading cannabis manufacturer. This investment recognizes the fast-growing market potential of cannabis and positions Altria to capitalize on the evolving legal landscape surrounding marijuana. With changing attitudes and increasing legalization, Altria's stake in Cronos is a strategic move to future-proof its business. Looking ahead, Altria has announced its plans to acquire Njoy Holdings in 2023. This move demonstrates Altria's commitment to innovation in the tobacco industry and its willingness to adapt to changing consumer preferences. The acquisition of Njoy, a prominent e-cigarette manufacturer, aligns with Altria's ongoing efforts to diversify its product offerings and cater to evolving consumer demands. In light of recent developments, Altria has also made headlines for its decision to exit its strategic investment in Juul Labs, a prominent e-cigarette company. While the reasons behind this move may vary, it highlights Altria's commitment to responsible business practices and its dedication to aligning with legal and regulatory frameworks. This decision also allows Altria to refocus its efforts on other ventures and pursue opportunities that align more closely with their long-term strategies. Overall, Altria's reach extends far beyond the realm of tobacco. With its diverse portfolio of subsidiaries and strategic investments, the company has positioned itself for continued success in various industries. From dominating the U.S. tobacco market to expanding into cannabis and exploring e-cigarette ventures, Altria remains a formidable force poised for growth and adaptation in a rapidly changing business landscape.

Website: https://www.altria.com

Data updated: June 2, 2026

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Consumer Defensive · 261 peers in sector

Metric MO Sector median Vs. industry
P/E 14.33 18.41 ↓ Below average
EPS 4.79 USD 0.29 USD ↑ Above average
Dividend yield 6.04% 0.00% ↑ Above average
Profit margin 39.52% 1.52% ↑ Above average
ROE 0.00% 2.66% ↓ Below average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

Sign up for free

AI Summary

AI-generated company analysis is available for registered users.

Sign up for free

Where does this data come from?

Frequently Asked Questions

What is Altria Group?
Altria, a multinational conglomerate, is a powerhouse in the tobacco industry. With its subsidiaries including Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, and Helix Innovations, Altria commands a significant market share and holds a prominent position in the United States. In addition to its tobacco ventures, Altria has diversified its portfolio by investing in other sectors. One notable investment is Altria's 10% interest in Anheuser-Busch InBev, the world's largest brewer. This strategic partnership allows Altria to tap into the lucrative global beer market and diversify its revenue streams. The collaboration strengthens Altria's position in the consumer goods industry and provides opportunities for future growth. However, it is in the tobacco sector where Altria truly shines. Through its tobacco subsidiaries, the company reigns supreme in the U.S. market, dominating both the cigarette and smokeless tobacco segments. Altria's Marlboro brand, iconic and renowned, is the crown jewel in its cigarette portfolio. With an impressive 43% annual share in 2022, Marlboro boasts unparalleled popularity and consumer loyalty. But Altria's ambitions don't stop at tobacco. The company has set its sights on the emerging cannabis industry. Altria holds a significant 42% stake in Cronos, a leading cannabis manufacturer. This investment recognizes the fast-growing market potential of cannabis and positions Altria to capitalize on the evolving legal landscape surrounding marijuana. With changing attitudes and increasing legalization, Altria's stake in Cronos is a strategic move to future-proof its business. Looking ahead, Altria has announced its plans to acquire Njoy Holdings in 2023. This move demonstrates Altria's commitment to innovation in the tobacco industry and its willingness to adapt to changing consumer preferences. The acquisition of Njoy, a prominent e-cigarette manufacturer, aligns with Altria's ongoing efforts to diversify its product offerings and cater to evolving consumer demands. In light of recent developments, Altria has also made headlines for its decision to exit its strategic investment in Juul Labs, a prominent e-cigarette company. While the reasons behind this move may vary, it highlights Altria's commitment to responsible business practices and its dedication to aligning with legal and regulatory frameworks. This decision also allows Altria to refocus its efforts on other ventures and pursue opportunities that align more closely with their long-term strategies. Overall, Altria's reach extends far beyond the realm of tobacco. With its diverse portfolio of subsidiaries and strategic investments, the company has positioned itself for continued success in various industries. From dominating the U.S. tobacco market to expanding into cannabis and exploring e-cigarette ventures, Altria remains a formidable force poised for growth and adaptation in a rapidly changing business landscape.
Are Altria Group shares expensive?
The price-to-earnings (P/E) ratio of Altria Group is 14.33 — the share price is 14.33 times the annual profit per share. That is lower than the typical company in the same industry (industry median: 18.41). This is information, not a recommendation. (as of 2026-06-02)
How big is Altria Group?
The market capitalization of Altria Group — the combined value of all its shares — is 114.64 B USD. The higher the market cap, the larger the company. (as of 2026-06-02)
Does Altria Group pay dividends?
The dividend yield of Altria Group is 6.04% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-02)
What sector does Altria Group belong to?
Altria Group operates in the Consumer Defensive sector, industry: Tobacco.

What do you gain?

With Ecrumen you gain full control over your investments and assets!

All your assets
Stock market investments, real estate, bonds. Be aware of what you have in your portfolio!
AI at the service of your investments
Analyze and optimize your investments using the latest technologies. Sentiments, analyses, tips, reports. Always with up-to-date data!
A community eager to help
Find a place with people similar to you. Share your opinions, see how others manage their investments. Get help with the problems that bother you!
What do you gain?

Want to stay up to date?

Subscribe to our newsletter to stay up to date with Ecrumena news and market information. No spam, unsubscribe in one click.

For more information, please refer to our terms of use.

0/120